These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24942315)

  • 21. Effect of Four Commonly Used Dissolution Media Surfactants on Pancreatin Proteolytic Activity.
    Guncheva M; Stippler E
    AAPS PharmSciTech; 2017 May; 18(4):1402-1407. PubMed ID: 27586964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures.
    Dey M; Enever R; Kraml M; Prue DG; Smith D; Weierstall R
    Pharm Res; 1993 Sep; 10(9):1295-300. PubMed ID: 8234166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of cross-linking on the in vivo disintegration of hard gelatin capsules.
    Brown J; Madit N; Cole ET; Wilding IR; Cadé D
    Pharm Res; 1998 Jul; 15(7):1026-30. PubMed ID: 9688055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hard gelatin and hypromellose (HPMC) capsules: estimation of rupture time by real-time dissolution spectroscopy.
    El-Malah Y; Nazzal S; Bottom CB
    Drug Dev Ind Pharm; 2007 Jan; 33(1):27-34. PubMed ID: 17192248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture.
    Digenis GA; Sandefer EP; Page RC; Doll WJ; Gold TB; Darwazeh NB
    Pharm Res; 2000 May; 17(5):572-82. PubMed ID: 10888309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sodium lauryl sulfate in dissolution media on dissolution of hard gelatin capsule shells.
    Zhao F; Malayev V; Rao V; Hussain M
    Pharm Res; 2004 Jan; 21(1):144-8. PubMed ID: 14984269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D; Bindra DS
    Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors affecting zero-order release kinetics of porous gelatin capsules.
    Chen GL; Hao WH
    Drug Dev Ind Pharm; 1998 Jun; 24(6):557-62. PubMed ID: 9876623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gelatin and Non-Gelatin Capsule Dosage Forms.
    Gullapalli RP; Mazzitelli CL
    J Pharm Sci; 2017 Jun; 106(6):1453-1465. PubMed ID: 28209365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F; Jones BE
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-line ATR-UV and Raman Spectroscopy for Monitoring API Dissolution Process During Liquid-Filled Soft-Gelatin Capsule Manufacturing.
    Wan B; Zordan CA; Lu X; McGeorge G
    AAPS PharmSciTech; 2016 Oct; 17(5):1173-81. PubMed ID: 26604007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic activity in the presence of surfactants commonly used in dissolution media, Part 1: Pepsin.
    Guzman ML; Marques MR; Olivera Me ME; Stippler ES
    Results Pharma Sci; 2016; 6():15-9. PubMed ID: 27047734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers.
    Chong RH; Jones BE; Díez F; Birchall JC; Coulman SA
    Int J Pharm; 2016 Mar; 500(1-2):316-25. PubMed ID: 26806464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D Printing and Dissolution Testing of Novel Capsule Shells for Use in Delivering Acetaminophen.
    Gaurkhede SG; Osipitan OO; Dromgoole G; Spencer SA; Pasqua AJD; Deng J
    J Pharm Sci; 2021 Dec; 110(12):3829-3837. PubMed ID: 34469748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of QbD principles for the evaluation of empty hard capsules as an input parameter in formulation development and manufacturing.
    Stegemann S; Connolly P; Matthews W; Barnett R; Aylott M; Schrooten K; Cadé D; Taylor A; Bresciani M
    AAPS PharmSciTech; 2014 Jun; 15(3):542-9. PubMed ID: 24526655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissolution testing of soft shell capsules-acetaminophen and nifedipine.
    Bottom CB; Clark M; Carstensen JT
    J Pharm Sci; 1997 Sep; 86(9):1057-61. PubMed ID: 9294822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M; Rothenhäusler B; Röthlisberger D
    Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Enzymes and Sodium Lauryl Sulfate on the Surface Tension of Dissolution Media: Toward Understanding the Solubility and Dissolution of Carvedilol.
    Hamed R; Alnadi SH; Awadallah A
    AAPS PharmSciTech; 2020 May; 21(5):146. PubMed ID: 32435989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.